Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMRIGadoxetic acid-enhanced MRI changing understanding of liver diseasesThe contrast agent is changing approaches toward diagnosis of liver diseases, according to data collected over the last 15 years.CTDeep-learning model predicts mortality from CTA scansWomens ImagingScreening breast MRI may be considered for high-risk womenWomens ImagingWomen's Imaging MinnieCast, Episode 20: Could DBT performance inform age-based screening?Sponsor ContentFree Webinar: Agentic AI in Radiology